ACET Q1 2018 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-8.32

QoQ Revenue Growth

+100.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$137M

Total Liabilities

$7M

Stockholders' Equity

$130M

Cash & Equivalents

$136M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$190M	-100.0%
Gross Profit	$0	$42M	-100.0%
Operating Income	-$10M	$13M	-177.3%
Net Income	-$10M	$6M	-276.4%

Revenue Segments

Human Health

$92M49%

Performance Chemicals

$51M27%

Pharmaceutical Ingredients

$43M23%